Deep Genomics develops a machine learning technology to understand how genetic variations lead to diseases. It develops an integrated computational system that could learn, predict and interpret how genetic variation, whether natural or therapeutic, alters crucial cellular processes. The Company offers SPIDEX database, which is a set of genetic variants and their predicted effects on human splicing across the entire genome.
|Employees (est.) (Jan 2021)||55||(+4%)|
Deep Genomics total Funding
Deep Genomics latest funding size
Time since last funding
|a year ago|
Deep Genomics investors
|Khosla Ventures, True Ventures, Bloomberg Beta, Eleven Two Capital, Future Ventures, Amplitude Ventures, Magnetic Ventures|
Deep Genomics has 3.27k Twitter Followers. The number of followers has increased 0.5% month over month and increased 1.3% quarter over quarter
When was Deep Genomics founded?
Deep Genomics was founded in 2014.
Who are Deep Genomics key executives?
Deep Genomics's key executives are Brendan Frey.
How many employees does Deep Genomics have?
Deep Genomics has 55 employees.
Who are Deep Genomics competitors?
Competitors of Deep Genomics include Acerta, Curai Health and Winterlight.
Where is Deep Genomics headquarters?
Deep Genomics headquarters is located at 661 University Ave #480, Toronto.
Where are Deep Genomics offices?
Deep Genomics has an office in Toronto.
How many offices does Deep Genomics have?
Deep Genomics has 1 office.
Receive alerts for 300+ data fields across thousands of companies